(Q37053662)

English

Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects.

scientific article published on January 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Florian M Reichle

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

Peter F Conzen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

language of work or name

1 reference

1 January 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

published in

Current Opinion in Investigational Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

page(s)

90-100

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 December 2019

Identifiers

PubMed publication ID

18183536

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18183536

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18183536%20AND%20SRC:MED&resulttype=core&format=json

(Q37053662)

Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)